Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aurograb plus Vancomycin in Severe Staphylococcal Infections
NCT00217841Phase 3Completed
- Sponsor
- Neutec Pharmaceuticals
- Start
- Jan 2004
- Modality
- Antibody Fragments
- Countries
- 1
01
Overview
A Phase 3 trial of Aurograb in staphylococcal infection, sponsored by Neutec Pharmaceuticals. Started Jan 2004; status: completed.
02
Drugs
Aurograb
03
Conditions
staphylococcal infection
Beyond the preview
Go deeper on NCT00217841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00217841.